Trader Edge
Publicado em 26/01/2026 às 14:10
Revolution Medicines (RVMD) Stock Falls as Merck Walks Away From Takeover Deal - Blockonomi
The proposed deal was reportedly valued between $28 billion and $32 billion
• Revolution Medicines stock fell after the breakdown in negotiations was reported
• The company’s experimental cancer drug ... [2841 symbols]
PUBLICIDADE